The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Volastra Therapeutics a biotechnology company specializing in cancer research has announced the commencement of the first patients dosing in a Phase III clinical trial evaluating VLS VLS in combination
SparX Biopharmaceutical Corp has achieved a significant milestone in the field of powered antibody therapies with the approval of its Investigational New Drug application for SPX by the US Food and Drug Administration
Merck KGaA Darmstadt Germany a prominent science and technology company has announced a strategic partnership with Jiangsu Hengrui Pharmaceuticals Co Ltd This collaboration involves an exclusive global
Atamyo Therapeutics a biotechnology company dedicated to advancing newgeneration gene therapies for the treatment of muscular dystrophies and cardiomyopathies has today unveiled the initial clinical
IDP Pharma a clinicalstage biotechnology company is pioneering the development of drugs that directly target and degrade intrinsically disordered proteins IDPs They have announced the successful dosing
AGC Biologics a prominent biopharmaceutical development and contract manufacturing organization has recently entered into a new service agreement with Medigene
TC BioPharm has revealed its partnership with Excellos a Contract Development Manufacturing Organization based in San Diego California Excellos which originated from the San Diego Blood Bank
Today the US Food and Drug Administration has granted its approval to Tibsovo for the treatment of adult patients with relapsed or refractory RR myelodysplastic syndromes who carry an isocitrate dehydrogenase
Endogena Therapeutics Inc a pioneering biotechnology company dedicated to advancing regenerative medicine is excited to announce a significant achievement with the potential to transform lives The US Food and Drug Administration
Genialis a company specializing in RNAbased biomarkers has announced a collaborative datasharing initiative with Cancer Research Horizons the innovation division of Cancer Research UK
